Patent · US Active

Methods of treating Mucopolysaccharidosis IIIB (MPSIIIB)

US10413597B2 · kind B2 · utility

0Cited by

11References

10Claims

0Family size

Assignee

Alexion Pharmaceuticals, Inc. · US

Inventors

Anthony Quinn · Sharon, US
Sandra Rojas-Caro · Waltham, US
Anthony Rossomando · Grafton, US
Robert John Lyng · Lexington, US
Kim Askew · Lexington, US
Nelson Hsia · Cambridge, US
Kiran Patki · Lexington, US

Key dates

Filing date	Sep 29, 2015
Grant date	Sep 17, 2019
Priority date	—
Expiry date	Nov 9, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y302/0105
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods for treating the central nervous system (CNS) in a human patient with mucopolysaccharidosis (MPS) MB who has an intact blood brain barrier, comprising intravenous administration of recombinant NaGlu.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.